SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-580232
Filing Date
2016-05-05
Accepted
2016-05-05 17:26:26
Documents
63
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d170811d10q.htm 10-Q 416288
2 EX-31.1 d170811dex311.htm EX-31.1 8131
3 EX-31.2 d170811dex312.htm EX-31.2 8114
4 EX-32.1 d170811dex321.htm EX-32.1 3879
  Complete submission text file 0001193125-16-580232.txt   3070321

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20160331.xml EX-101.INS 564778
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20160331.xsd EX-101.SCH 38617
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20160331_cal.xml EX-101.CAL 54532
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20160331_def.xml EX-101.DEF 126271
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20160331_lab.xml EX-101.LAB 317436
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20160331_pre.xml EX-101.PRE 228099
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 161625125
SIC: 2834 Pharmaceutical Preparations